<$BlogRSDUrl$>

News, Links and Commentary

Wednesday, September 06, 2006

Diary of an MD Patient Treated with Avastin 

New Zealander Simon James is about to undergo his second treatment with Avastin for myopic macular degeneration. Simon is 22 years old and significantly younger than most people affected by macular degeneration. You can read about his treatment, which has so far brought positive results, in My Eyes Diary.

Avastin is the drug produced by Genentech and which some ophthalmologists are using as a cheaper alternative to Genentech's Lucentis.

Comments:
Gοod day! I coulԁ have ѕworn I've been to this web site before but after looking at many of the posts I realized it's new to me.
Νonеtheless, Ι'm definitely delighted I stumbled upon it and I'll be bοokmarκing it and
checking back oftеn!
Also see my webpage :: business news
 
Post a Comment

This page is powered by Blogger. Isn't yours?